Tyrosine kinase inhibitors and immune checkpoint inhibitors-induced thyroid disorders-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tyrosine kinase inhibitors and immune checkpoint inhibitors-induced thyroid disorders

Published:2019-09 Issue: Volume:141 Page:23-35
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Jannin Arnaud^ORCID,Penel Nicolas^ORCID,Ladsous Miriam,Vantyghem Marie Christine,Do Cao Christine

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference141 articles.

1. Risk of thyroid dysfunction in patients with solid tumors treated with VEGF receptor tyrosine kinase inhibitors: a critical literature review and meta analysis;Abdel-Rahman;Expert Rev. Anticancer Ther.,2014

2. Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination;Abdulrahman;J. Clin. Endocrinol. Metab.,2010

3. Real-world use of sunitinib in Japanese patients with advanced renal cell carcinoma: efficacy, safety and biomarker analyses in 1689 consecutive patients;Akaza;Jpn. J. Clin. Oncol.,2015

4. Unique cytologic features of thyroiditis caused by immune checkpoint inhibitor therapy for malignant melanoma;Angell;Genes Dis.,2018

5. Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study;Antonia;Lancet Oncol.,2016

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Underlying mechanisms and management strategies for regorafenib-induced toxicity in hepatocellular carcinoma;Expert Opinion on Drug Metabolism & Toxicology;2024-09-03

2. Clinical Features and Determinants of Disease Severity of Immune Checkpoint Inhibitor-Related Pneumonitis: A Retrospective Study;2024-04-03

3. Factors associated with immune-related thyroid dysfunction induced by PD-1/PD-L1 inhibitors in cancer patients: an observational study;Journal of Chemotherapy;2024-01-19

4. Endocrine Complications of the Hematologic Disorders and of Their Treatment;Reference Module in Biomedical Sciences;2024

5. Higher thyroid hormone levels and cancer;Vitamins and Hormones;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3